GuiZhou SanLi Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -35.41% vs 53.87% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -102.12% vs 40.14% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "336.70",
          "val2": "521.30",
          "chgp": "-35.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.00",
          "val2": "112.90",
          "chgp": "-100.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.70",
          "val2": "80.30",
          "chgp": "-102.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.00%",
          "val2": "180.30%",
          "chgp": "-18.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 31.08% vs 36.05% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -5.12% vs 53.67% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,125.80",
          "val2": "1,621.70",
          "chgp": "31.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "400.50",
          "val2": "307.00",
          "chgp": "30.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.60",
          "val2": "4.20",
          "chgp": "247.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "279.80",
          "val2": "294.90",
          "chgp": "-5.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "152.60%",
          "val2": "166.10%",
          "chgp": "-1.35%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

336.70

521.30

-35.41%

Operating Profit (PBDIT) excl Other Income

-1.00

112.90

-100.89%

Interest

0.50

0.00

Exceptional Items

0.10

0.00

Consolidate Net Profit

-1.70

80.30

-102.12%

Operating Profit Margin (Excl OI)

-3.00%

180.30%

-18.33%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is -35.41% vs 53.87% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -102.12% vs 40.14% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2,125.80

1,621.70

31.08%

Operating Profit (PBDIT) excl Other Income

400.50

307.00

30.46%

Interest

14.60

4.20

247.62%

Exceptional Items

0.10

-0.00

Consolidate Net Profit

279.80

294.90

-5.12%

Operating Profit Margin (Excl OI)

152.60%

166.10%

-1.35%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 31.08% vs 36.05% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -5.12% vs 53.67% in Dec 2023

All Annual Results